| aCSF | D2AODN | D2random AODN |
---|
SN | AM | 1.00 ± 0.01 | 0.76 ± 0.06# | 1.33 ± 0.13 |
PM | 0.78 ± 0.02** | 0.86 ± 0.03 | 0.99 ± 0.05* |
VTA | AM | 1.02 ± 0.02 | 0.42 ± 0.02## | 1.38 ± 0.19 |
PM | 0.77 ± 0.01** | 0.46 ± 0.06# | 0.53 ± 0.08** |
- Data are expressed as mean ± SEM (n = 8-12 rats in each group). *, p < 0.05; **, p < 0.01, compared with respective control groups in the morning; #, p < 0.05; ##, p < 0.01 compared with respective aCSF-treated groups at the same time point.
- Groups of OVX+E2 rats received icv injections of aCSF, antisense oligodeoxynucleotides (AODN, 10 μg/3 μl), or random AODN against D2 receptor mRNA for 2 days were sacrificed either in the morning or afternoon.